Suppr超能文献

惊恐障碍中下丘脑-垂体-肾上腺皮质系统的调节异常。

Dysregulation of the hypothalamic-pituitary-adrenocortical system in panic disorder.

作者信息

Schreiber W, Lauer C J, Krumrey K, Holsboer F, Krieg J C

机构信息

Department of Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.

出版信息

Neuropsychopharmacology. 1996 Jul;15(1):7-15. doi: 10.1016/0893-133X(95)00146-5.

Abstract

The responsiveness of the hypothalamic-pituitary-adrenocortical (HPA) system was investigated with the combined dexamethasone-corticotropin-releasing hormone (DEX-CRH) challenge test in 13 patients with "pure" panic disorder. After DEX pretreatment, this group of patients had higher CRH-induced adrenocorticotrophic hormone (ACTH) and cortisol levels than the control group, but lower than a reference group of depressed patients. The panic disorder patients were also in a middle position in the ratio of suppressors to nonsuppressors on the dexamethasone suppression test (DST) and in the ratio of normal to abnormal results on the DEX-CRH test. Our results using the combined DEX-CRH test, which is known to be much more sensitive than the original DST, support the hypothesis that HPA system functioning is altered in panic disorder patients and that this dysregulation is directly involved in the pathogenesis of the disorder.

摘要

采用联合地塞米松 - 促肾上腺皮质激素释放激素(DEX - CRH)激发试验,对13例“单纯”惊恐障碍患者的下丘脑 - 垂体 - 肾上腺皮质(HPA)系统反应性进行了研究。地塞米松预处理后,该组患者促肾上腺皮质激素释放激素(CRH)诱导的促肾上腺皮质激素(ACTH)和皮质醇水平高于对照组,但低于抑郁症参考组。惊恐障碍患者在地塞米松抑制试验(DST)中抑制者与非抑制者的比例以及DEX - CRH试验中正常与异常结果的比例也处于中间位置。我们使用联合DEX - CRH试验(已知该试验比原始DST更敏感)的结果支持以下假设:惊恐障碍患者的HPA系统功能发生改变,并且这种调节异常直接参与了该疾病的发病机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验